Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Chemokine signaling pathway | R-HSA-168638 | map04062 | fludrocortisone | 31378 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | fludrocortisone | 31378 | drug-path |
| Proteasome | R-HSA-68819 | map03050 | fludrocortisone | 31378 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | fludrocortisone | 31378 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | fludrocortisone | 31378 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | milrinone | 4197 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | milrinone | 4197 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | milrinone | 4197 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | milrinone | 4197 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | milrinone | 4197 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | milrinone | 4197 | drug-path |
| Asthma | R-HSA-444620 | map05310 | milrinone | 4197 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | milrinone | 4197 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | milrinone | 4197 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | milrinone | 4197 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | milrinone | 4197 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | milrinone | 4197 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | dexpropranolol | 446541 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | dexpropranolol | 446541 | drug-path |
| mTOR signaling pathway | R-HSA-165662 | map04150 | dexpropranolol | 446541 | drug-path |